Navigation Links
China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011
Date:5/16/2011

KUNMING, China, May 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today reported unaudited financial results for the first quarter ended March 31, 2011.

First Quarter 2011 Highlights

  • Total revenue increased to $9.4 million for the first quarter of 2011, representing 19% year-over-year growth.
  • Net cash provided by operating activities was approximately $2.6 million, an increase of approximately $0.6 million, from approximately $2.0 million for the first quarter ended March 31, 2010.
  • Net income attributable to stockholders increased to $99,373, as compared to $2,355 for the first quarter ended March 31, 2010.

    • First Quarter 2011 ResultsSales: Sales for the three months ended March 31, 2011 was approximately $9.4 million, an increase of approximately $1.5 million, or 19 %, from approximately $7.9 million for the three months ended March 31, 2010. The increase in sales was primarily due to the Company's main product Xuesaitong's sales increasing in Tianjin City and Yunnan Province as Xuesaitong was listed on the Provincial Insurance Catalog list of Tianjin City since the second quarter in 2010 and the Company strengthened sales promotion in Yunnan Province.

    Cost of goods sold: Our cost of goods sold for the three months ended March 31, 2011 was approximately $3.8 million, an increase of $1.7 million, or 83%, from approximately $2.1 million for the three months ended March 31, 2010. The increase in cost of goods sold was primarily due to the increase of purchase price of Sanqi which is the main raw material of our main product Xuesaitong. In addition, the Zhonghuang Hotel began trial operation since January 2011 which has contributed $0.4 million to the increase of cost of goods sold.

    Gross profit: Our gross pr
    '/>"/>

    SOURCE China Shenghuo Pharmaceutical Holdings, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. China Pharma Holdings, Inc. to Present at the Eighth Annual Piper Jaffray China Growth Conference in New York on May 17, 2011
    2. Winner Medical to Present at Oppenheimer 5th Annual China Dragon Conference
    3. Naviscan Announces Partnership With Chindex Medical Limited for Mainland China, Hong Kong and Macau
    4. China New Borun Announces First Quarter 2011 Financial Results
    5. China Pharma Holdings, Inc. Reports First Quarter 2011 Financial Results
    6. Reportlinker Adds Orthopedic Devices Market in the Emerging Countries (China, India, Brazil) - Presenting New Avenues for Growth and Profitability
    7. Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China
    8. China Medical Technologies to Present at Jefferies 2011 Global Healthcare Conference on June 7, 2011
    9. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
    10. China Sky One Medical Announces Conference Call to Discuss First Quarter 2011 Results
    11. ICSE China to Offer Inaugural Conference Programme in 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/22/2014)... , July 22, 2014 The National ... operate the Center for Space Radiation Research (CSRR) under ... Boerma is an Associate Professor of Pharmaceutical Sciences within ... of Pharmacy Division of Radiation Health. She is located ... will direct a team of investigators working across four ...
    (Date:7/22/2014)... Mass. , July 22, 2014  Decision Resources Group ... Canada will remain relatively stagnant at ... despite the fact that percutaneous coronary intervention (PCI) volumes are ... other developed markets, such as the United States ... will be largely driven by the increase in penetration of ...
    (Date:7/22/2014)... , July 22, 2014  Decision Resources ... multiple sclerosis (MS) patients currently treated with ... have ever experienced flushing and/or gastrointestinal events ... patients are currently experiencing these side effects, ... effective medical management of such events. In ...
    Breaking Medicine Technology:Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 3The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3
    ... May 26 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in ... its 2010 Annual Meeting of Stockholders and Open House on June 2 from ... , , , ... , , ...
    ... May 25 Otix Global, Inc. (Nasdaq: OTIX ), ... begun offering franchising opportunities to audiologists and audiometrists throughout Australia ... annual Audiological Society of Australia (ASA) conference in Darling ... American Academy of Audiology conference which is held in the U.S. ...
    Cached Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at Its 2010 Annual Meeting of Stockholders and Open House 2Isis Pharmaceuticals to Present a General Corporate Update at Its 2010 Annual Meeting of Stockholders and Open House 3Otix Global to Offer Franchise Opportunities in Australia 2Otix Global to Offer Franchise Opportunities in Australia 3
    (Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... who are obese during pregnancy may be more likely to ... suggests. "We found that, compared with children born from ... obese during pregnancy had up to 20 to 30 percent ... an assistant professor of pediatrics at Children,s Hospital of Pittsburgh. ...
    (Date:7/22/2014)... hysterectomy using electric power morcellation, uterine cancers were present ... the procedure, according to a study published by ... in which the uterus is fragmented into smaller pieces, ... Despite the commercial availability of electric power morcellators for ... at the time of electric power morcellation (in this ...
    (Date:7/22/2014)... heart disease, Dr. Ross Feldman says women are often in ... a men,s-only disease, however, data has shown that post-menopausal women ... and are less likely to be adequately diagnosed and treated. ... the British Journal of Clinical Pharmacology brings to ... helps to identify which women are more prone to heart ...
    (Date:7/22/2014)... July 22, 2014 As reported on July ... caller request to name her favorite beauty products, “ Botox ... to say that “ Botox has changed my life” ... makeup chair preparing for her various, daily appearances. “Suddenly ... Ms. Ripa (see: goo.gl/shmTQM). , “I think that Kelly Ripa’s ...
    (Date:7/22/2014)... Rochelle, NY -- New guidelines on cholesterol treatment and ... double the risk of dying from atherosclerotic cardiovascular disease ... do women with a similar risk profile (based on ... The implications of this finding for when and how ... Editorial in Journal of Men,s Health , a ...
    Breaking Medicine News(10 mins):Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 2Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 3Health News:Study examines presence of uterine cancers at the time of hysterectomy using morcellation 2Health News:Gene variant identified as a heart disease risk factor for women 2Health News:Celebrity Botox: Kelly Ripa Confesses to Getting Botox Injections 2
    ... TUESDAY, May 29 (HealthDay News) -- People with less than ... problems with their thinking skills later in life, according to ... researchers from Harvard University noted that people with more education ... thinking, or so-called "cognitive," skills, even if they had the ...
    ... HealthDay Reporter , MONDAY, May 28 (HealthDay News) -- Could ... friends sit around? A small study suggests it,s possible: ... they hung out with active kids, and the reverse was ... affect how active kids are, and it,s not clear whether ...
    ... for suspected HIV is critical, pre-exposure preventive treatment is ... in high-risk groups, states a review of evidence published ... "Although postexposure prophylaxis has a long history of success, ... in the course of infection ("treatment as prevention") are ...
    ... May 27 (HealthDay News) -- Boosting students, levels of ... says. Swedish researchers followed more than 200 schoolchildren, ... Some children were assigned to an intervention group that ... training in motor-physical skills such as balance and coordination. ...
    ... from the U.S. Preventive Services Task Force (USPSTF) advising ... cancer in healthy men are likely to encounter serious ... a survey by Johns Hopkins investigators. In ... found that while doctors agreed with older recommendations to ...
    ... factor receptor cousins mobilize a specialized protein to activate a ... in the May 25 issue of Cell . ... in breast cancer and activation of glucose metabolism (glycolysis), which ... survive. Their research focused on Skp2 E3 ligase, a ...
    Cached Medicine News:Health News:Education May Protect Brain From Exposure to Solvents 2Health News:Key to More Active, Slimmer Kids: Friends 2Health News:Antiretroviral treatment for preventing HIV infection: an evidence review for physicians 2Health News:New prostate cancer screening guidelines face a tough sell, study suggests 2Health News:New prostate cancer screening guidelines face a tough sell, study suggests 3Health News:Skp2 activates cancer-promoting, glucose-processing Akt 2Health News:Skp2 activates cancer-promoting, glucose-processing Akt 3
    The flexible endoscope was mainly developed for the pure neuroendoscopy. Due to the working channel it is ideal suitable for therapeutic indications e.g. subdural hematomas, cysts or intraventricular...
    Bipolar gingivoplasty loop. Individual sterile packs....
    ... Performance Instrument System. It is the only ... electric power with the unparalleled high performance ... The advanced design of this instrument system ... cooling system, advanced control circuitry, and the ...
    ... is a high speed pneumatic ... dissection of bone, biometals, bioplastics ... not only provides speed 80,000 ... the control and precision that ...
    Medicine Products: